Analytica Stock

Analytica FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Analytica (ALT.AX) as of Aug 6, 2026 is 103.24 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 107.23 % — a change of -3.72% (lower).

FCF Conversion

103.24 %

YoY

-3.72%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Analytica is 2026 103.24 % . FCF Conversion Rate (FCF/EBITDA) of Analytica was 2025 107.23 % . It decreases by -3.72% lower compared to the previous year.
Access this data via the Eulerpool API

Analytica Stock analysis

What does Analytica do? Analytica Ltd is a British company that was founded in 1970 by Dr. John Smith. Originally, it specialized in the development of analysis instruments for the chemistry and life sciences, particularly liquid chromatography. Over the years, the company expanded its offerings and now provides a wide range of products and services. Analytica Ltd has become a global company with a presence in over 130 countries. It operates in various business areas, including analytical chemistry, bioanalysis, environmental and food analysis, and clinical diagnostics. The company offers customers a wide range of products, such as chromatography systems, mass spectrometers, specialized analysis devices, and consumables. It has also specialized in the development and manufacturing of medical devices, including diagnostic tools for conditions such as diabetes, cholesterol, and other metabolic diseases. Analytica Ltd incorporates innovative technologies like miniaturization and nanotechnology into its products. In addition to product sales, Analytica Ltd provides tailored services. The company has highly qualified experts who assist customers with method development, process optimization, and data interpretation. It also conducts research and development programs to continuously develop new products and technologies. Analytica Ltd maintains numerous collaborations and partnerships with other companies and organizations. For example, it works closely with research institutions and universities to develop new technologies and products. The company also connects with other companies in the health and analytical industries to share innovations and best practices. Overall, Analytica Ltd is a leading provider of analysis solutions for the pharmaceutical, biotech, chemical, and food industries, as well as research institutions and clinical laboratories. The company is continuously working to further develop its products and services to meet the needs of its customers and address the ever-changing challenges of the industry. Analytica is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Analytica stock

FCF Conversion Rate (FCF/EBITDA) of Analytica is 103.24 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Analytica changed from 107.23 % to 103.24 %, representing a -3.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Analytica since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Analytica with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Analytica

All Key Metrics — Analytica